Strike Out Stroke

Urgent coordinated action is needed to avoid the thousands of preventable strokes that leave many atrial fibrillation (AF) patients mentally and physically disabled or dead, every year. A report, How Can We Avoid a Stroke Crisis?, was launched in the European Parliament in December 09 by Action for Stroke Prevention, a group of health experts from across Europe, proposes measures to tackle stroke in patients with AF, the most common, sustained abnormal heart rhythm and a major cause of stroke. Their proposal, endorsed by 17 leading European medical professional and patient organisations, calls for EU policy makers and Member State governments to act before the increasing frequency of these strokes becomes a major public health crisis.

The Report warns of a stroke epidemic across Europe, if actions are not taken now to slow the rising tide of preventable strokes occurring every year.Linda McAvan, Member of the European Parliament (MEP),commented, “It is important that government and healthcare policy makers take action to address the unmet medical needs in stroke prevention. I support the recommendations made in the Report by Action for Stroke Prevention, and believe that their implementation will contribute to the prevention of stroke in patients with AF and, in turn, reduce the dramatically increasing clinical, economic and social burden of stroke in Europe.”

Recommendations made by the Report include: improving patient education, AF diagnosis and stroke risk assessment, taking new approaches to prevention, facilitating the exchange of best practice between Member States, developing strategies to support adherence to guidelines, and the provision of equal and adequate administration of therapy for patients with AF.

The full report can be read or downloaded here.

 
Patients capable of self-monitoring their anticoagulation therapy

Patients capable of self-monitoring their warfarin therapy could benefit from a one-third reduction in death from all causes, according to a meta-analysis in this week's issue of The Lancet. However, self-monitoring is not feasible for all patients, and requires identification and education of suitable candidates, state the authors of the study.

Read more...
 
Expert pharmacists get the go ahead

Pharmacists with Special Interests (PhwSIs) are to offer care and advice about diabetes, and long-term conditions on patients doorsteps

Patients with long-term conditions will soon be able to manage their diabetes or heart disease when they pop to the shops thanks to a new breed of 'expert pharmacists'

Read more...
 
Ongoing trials for new oral anticoagulant

Study shows dabigatran etexilate, a new oral anticoagulant, is effective and safe in preventing thromboembolic disease after orthopaedic surgery

In future, the prevention of venous thromboembolism (VTE) in patients after knee-replacement surgery might become much easier with a new agent in capsule form, called dabigatran etexilate. Dabigatran etexilate is an oral direct thrombin inhibitor, a new oral anticoagulant in advanced development.

Read more...
 
New guidelines for atrial fibrillation

Issued by the National Institute for Clinical Excellence
 
New guidelines aim to increase the identification and treatment of atrial fibrillation (AF) a 'hidden disease' that is the commonest sustained cardiac rhythm disorder.

The condition is important to diagnose early as it is a major risk factor for stroke - people with AF have a one in twenty chance of having a stroke. The new guidance will help GPs and other healthcare professionals recognise and treat AF.

Read more...
 
<< Start < Prev 1 2 Next > End >>

Page 1 of 2

Fundraising

We rely on donations to continue our work.Click here to donate.

Our Newsletter

Our email newsletter keeps you up to speed. Click here to sign up.

Next Event

No events

Featured Campaign

Find out about our Stop the Clot campaign. Click here for details.